AIDS Alert Archives – April 1, 2009
April 1, 2009
View Issues
-
HIV treatment costs balloon for clinics as funding remains flat
If President Barack Obama's FY2010 budget does send millions of dollars to HIV/AIDS treatment and prevention programs, the money will arrive none too soon, HIV clinicians and researchers say. -
Bureaucracy creates huge burden for HIV clinics
Even with flat-funding, increased patient loads, and a chronic disease that continues to be complex to treat, HIV providers could manage well enough if it weren't for the unfunded burden of bureaucratic paperwork and rules, some say. -
Adherence can cause increase in direct ART and health care costs
At least in the short-term, higher adherence can lead to higher direct health care costs in treating HIV patients, researchers reveal. -
New female condom clears FDA committee
The only existing female-initiated and controlled HIV prevention method, female condoms can reduce the risk of HIV transmission by some 90%. -
Abstract & Commentary: Better than nothing: Keeping pts on failing regimen has benefits
For this study, 12,765 patients from the large French Hospital Database for HIV with CD4+ lymphocyte counts < 200 cells/uL who received cART during 2000-2005 were selected. -
FDA Notifications: FDA grants approval for raltegravir
On Jan. 29, 2009, the Food and Drug Administration (FDA) granted traditional approval for raltegravir (Isentress) 400 mg tablets in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients.